Cardamom

What is Cardamom?

Green cardamom seed carries 6.6 to 10.6 percent volatile oil by weight, and two compounds, 1,8-cineole and alpha-terpinyl acetate, account for roughly 65 to 85 percent of that oil. Those two numbers govern almost everything that follows, including whether the product you buy does anything at all.

Cardamom is the dried fruit of Elettaria cardamomum (L.) Maton, a perennial rhizomatous herb in the Zingiberaceae, the same family as ginger and turmeric. It grows in the shade of the Western Ghats of southern India at roughly 600 to 1,500 meters. The harvested unit is a three-sided capsule, a pod 1 to 2 centimeters long holding 12 to 18 seeds in three chambers. The seeds hold the oil. The pod does not.

That division matters more for cardamom than for almost any other spice. ISO 882-1:1993, published 1 April 1993, covers whole capsules, and ISO 882-2:1993, published the same day, covers decorticated seeds. Both set the same minimum volatile oil content of 3.5 milliliters per 100 g on a dry basis, even though the husk yields only about 0.2 percent volatile oil. The pod is packaging, and a near oil-free husk riding along in the weight does not drag the assay below the floor, because the husk is doing its job of keeping the seed’s oil where it is.

World production reached 138,888 tonnes in 2022, with India at 41,000 tonnes, Indonesia at 40,565 tonnes and Guatemala at 36,407 tonnes, together 85 percent of the total. Guatemala passed India in the 1979 to 1980 season, roughly seventy years after the German planter Oscar Majus Kloeffer introduced the crop there. By weight, cardamom ranks third among the world’s most expensive spices, behind saffron and vanilla, at an average of 3,064.19 rupees per kilogram at the South Indian Cardamom Online Auction on 11 September 2026.

Common Names

• Green cardamom, true cardamom, small cardamom
• Elaichi, ilaichi (Hindi and Urdu); elakkai, elakka (Tamil and Malayalam)
• Cardamome verte (French), Kardamom (German), hel (Arabic and Hebrew)
• Queen of Spices, a trade term across the Indian spice industry
• Cardamomi fructus, the pharmacopoeial name in the German Commission E monograph

Primary Active Compounds

• 1,8-cineole (eucalyptol), 15.2 to 49.4 percent of the essential oil across 22 southern Indian accessions, mean 34.5 percent
• Alpha-terpinyl acetate, 29.9 to 61.3 percent across the same accessions, mean 43.5 percent
• Limonene, 0.9 to 9.4 percent across the same accessions
• Linalool 0.4 to 11.0 percent and linalyl acetate 0.2 to 4.4 percent
• Sabinene 1.9 to 4.9 percent, with myrcene, alpha-pinene and terpinen-4-ol lower still
• Cardamonin and alpinetin, chalcone and flavanone constituents in the non-volatile fraction

Key Note

Cardamom’s pharmacology is a volatile oil pharmacology. The minerals in the powder are trivial at any dose anyone eats, and the phenolic content is low: cardamom returned the lowest total phenolic value among four Zingiberaceae species tested by Ivanovic and colleagues in 2021, its water extract at 1.04 plus or minus 0.29 mg gallic acid equivalents per gram dry weight. Whatever cardamom does, it does through terpenes that evaporate.

That single fact is why the form you buy decides the outcome.

Primary Functions & Benefits

Metabolic and glycemic effects. Nameni and colleagues (2022, Diabetes and Metabolic Syndrome) combined 6 RCTs and 410 participants, all using 3 g per day for 8 weeks to 3 months. HOMA-IR fell (WMD -0.40; 95 percent CI -0.65 to -0.15; P = 0.00) and HbA1c fell (WMD -0.48; 95 percent CI -0.80 to -0.16; P = 0.00). Fasting blood sugar, insulin, BMI and weight showed no significant effect.

Lipids. Zhang and colleagues (2024, Nutrition Research) pooled 12 trials and 989 participants and found total cholesterol down 8.56 mg/dL (95 percent CI -14.90 to -2.22) and triglycerides down 14.09 mg/dL (95 percent CI -24.01 to -4.17), with no significant change in HDL-C or LDL-C.

Inflammation. The same analysis found hs-CRP down 1.01 ng/mL (95 percent CI -1.81 to -0.22) and IL-6 down 1.81 pg/mL (95 percent CI -3.06 to -0.56). Heydarian and colleagues (2024, Food Science and Nutrition) pooled 8 studies and reported hs-CRP SMD -0.60, IL-6 WMD -1.25 and TNF-alpha WMD -2.10.

Blood pressure. The same 8-study pool found systolic pressure down 0.54 mmHg (P = 0.002). Statistically significant, clinically negligible.

Hepatic markers. Daneshi-Maskooni and colleagues (2018, Nutrition and Metabolism) randomized 87 overweight or obese NAFLD patients to 3 g daily or placebo for 3 months and found ALT, hs-CRP, TNF-alpha, IL-6 and ultrasound fatty liver grade all reduced (P < 0.05), with AST, weight and BMI unchanged.

Nausea. Khatiban and colleagues (2022, Journal of PeriAnesthesia Nursing) randomized 70 women having cesarean delivery under spinal anesthesia to inhaled cardamom essential oil or saline. Nausea episodes occurred in 37.1 percent versus 65.7 percent (P = 0.006).

Digestive use. The German Commission E monograph approves cardamom fruit for dyspeptic complaints at 1.5 g daily, on traditional use rather than controlled trials.

Forms & Standardization

Whole green pods (capsules). The reference form. ISO 882-1:1993 requires a minimum of 3.5 ml volatile oil per 100 g on a dry basis, moisture at or below 13 percent, total ash at or below 9.5 percent, extraneous matter at or below 5 percent, empty and malformed capsules at or below 5 percent by count, and immature or shriveled capsules at or below 7 percent. The European Spice Association sets a tighter commercial minimum of 4.0 ml per 100 g volatile oil, 12 percent moisture, 9.0 percent ash and 2.5 percent acid-insoluble ash. Good lots test well above the ISO floor: across 22 southern Indian accessions analyzed by GC/MS by Ashokkumar and colleagues (2021, Frontiers in Sustainable Food Systems), essential oil ranged from 4.5 to 9.5 percent.

Decorticated seed. Seeds shelled out of the pod and sold loose. ISO 882-2:1993 sets the same 3.5 ml per 100 g minimum. Decorticated seed is more concentrated per gram than whole pods, since the husk contributes weight and only 0.2 percent oil, but it starts losing volatiles the day it is shelled. A compromise, not an upgrade.

Pre-ground powder. The worst form sold, and the one inside most capsules. The 2016 Anand Agricultural University work measured intact dehulled seed at 6.66 percent volatile oil with 1,8-cineole at 15.9 percent of that oil. After conventional ambient grinding the same material tested 3.00 percent oil (45.05 percent retention) and 4.2 percent cineole (26.42 percent retention). Cryogenic grinding at minus 40 degrees Celsius, 7 kg per hour feed rate and a 1.5 mm sieve preserved 5.8 percent oil (87.08 percent retention) and 12.80 percent cineole (80.50 percent retention), with alpha-terpinyl acetate at 14.10 percent. Almost nothing on a retail shelf is cryogenically ground, and nothing that is says so on a supplement label.

The storage curve on top of the grinding loss. The same study stored the best-case cryogenically ground powder for 90 days. At ambient 30 plus or minus 2 degrees Celsius, volatile oil went 5.8 percent at day 0, 4.4 at day 10, 3.6 at day 30, 3.2 at day 60 and 2.9 at day 90, a 50 percent loss. The 1,8-cineole marker went 12.8, 7.5, 5.8, 3.4 and 2.5 percent over the same days, an 80 percent loss. Refrigerated at 4 degrees the oil held better, 5.45 percent at day 30 and 4.4 at day 90, but cineole still fell to 3.0 percent. Stack the two measurements: conventional grinding keeps 45 percent of the oil, and three months of warm storage removes half of what survives. For the cineole marker the compounding is worse. Ogzewalla and Willins reported in 1962 that ground cardamom seed loses volatile oil so rapidly that after several months only a trace can be recovered, and the 2016 data quantifies it.

Steam-distilled or hydrodistilled essential oil. Yields about 5.0 percent from seed. Specific gravity runs 0.917 to 0.947 at 25 degrees Celsius, refractive index 1.463 to 1.466 at 20 degrees, ester number 92 to 150. The EFSA FEEDAP panel characterized a commercial cardamom seed oil in 2019 and identified 37 components accounting for more than 99 percent of the composition, with terpineol acetate above 35 percent and 1,8-cineole above 20 percent. This is a flavor material, FEMA 2241, CAS 8000-66-6, covered by 21 CFR 182.20. No oral trial of cardamom essential oil at gram-level doses exists in humans.

Supercritical CO2 extract. Marongiu, Piras and Porcedda (2004, Journal of Agricultural and Food Chemistry) optimized SC-CO2 extraction at 9.0 MPa, 40 degrees Celsius, a carbon dioxide flow of 1.2 kg per hour and a 250 to 425 micrometer particle size, reaching a yield of 5.5 percent. The extract ran alpha-terpinyl acetate 42.3 percent, 1,8-cineole 21.4 percent, linalyl acetate 8.2 percent, limonene 5.6 percent and linalool 5.4 percent, with no consistent difference from the hydrodistilled oil at 5.0 percent yield. Hexane gave a higher yield of 7.6 percent but a distorted profile: limonene 36.4 percent, 1,8-cineole 23.5 percent, terpinolene 8.6 percent. If a label says solvent extract without naming the solvent, that difference is what is hidden.

Standardized extracts. There is no accepted standardization marker for an oral cardamom supplement, no established extract ratio, and no USP monograph for cardamom as a dietary ingredient. A product advertising a 10:1 cardamom extract standardized to any percentage is describing something no trial has tested.

What the human trials actually used. Kazemi 2017, Fatemeh 2017, Aghasi 2019, Daneshi-Maskooni 2018 and 2019, and Cheshmeh 2022 all used 3 g per day of plain green cardamom powder in capsules, dosed in divided amounts across the day. None reports the volatile oil content of the powder encapsulated, the most important missing number in the clinical literature on this spice.

Food Sources

Cardamom is a spice, so food is the primary route and the pill is the derivative. USDA data for ground cardamom, per 100 g: 311 kcal, 10.8 g protein, 6.7 g fat, 68.5 g carbohydrate, 28.0 g dietary fiber, 383 mg calcium, 14.0 mg iron, 229 mg magnesium, 178 mg phosphorus, 1,119 mg potassium, 18 mg sodium, 7.5 mg zinc, 28.0 mg manganese, 21.0 mg vitamin C and 1.1 mg niacin.

Nobody eats 100 g of cardamom. One level teaspoon weighs roughly 2 g, which delivers 6.2 kcal, 0.56 g fiber, 0.56 mg manganese, 0.28 mg iron, 4.6 mg magnesium, 7.7 mg calcium and 22 mg potassium. Manganese is the only entry reaching a nutritionally interesting share of an adult reference intake, about 24 percent of the 2.3 mg adequate intake for men and 31 percent of the 1.8 mg for women. Even the 3 g trial dose provides only 0.84 mg manganese and 0.42 mg iron.

Whole pods. Eight to nine pods yield roughly one teaspoon of ground seed, a single pod about an eighth of a teaspoon. Crushed in a mortar immediately before use, whole pods deliver the volatile profile the trials nominally relied on.

Cardamom tea and coffee. Arabic qahwa and Indian masala chai both extract cardamom into hot liquid, a reasonable delivery route for a terpene-rich material. A cup made with 2 to 4 crushed pods carries a few tens of milligrams of volatile oil into the infusion. That is a plausible carminative dose and nowhere near the 600 mg per day of isolated 1,8-cineole used in respiratory trials.

Baking and cooking. Scandinavian cardamom buns, Indian biryani and kheer, Middle Eastern desserts and Ethiopian berbere blends use cardamom at 0.5 to 2 g per serving. Heat drives off volatiles, so cardamom added late retains more than cardamom simmered for an hour.

Post-harvest handling. Fresh capsules are dried from about 80 percent moisture down to 10 to 12 percent, at 40 to 45 degrees Celsius through most of the cycle with a final 50 to 55 degrees for 1 to 2 hours. Traditional flue curing takes 24 to 30 hours, improved automated dryers 16 to 18 hours, and dried capsules are held below 10 percent moisture in polythene-lined sacks or wooden boxes. Every step exists to protect the volatile oil, and every step is undone by a grinder.

Is food intake realistically sufficient? For culinary and digestive purposes, yes. The 3 g daily trial dose is about one and a half teaspoons of ground cardamom, an unpleasant but achievable amount across a day in strongly spiced food, tea or coffee. The trials used capsules precisely because 3 g of cardamom is a lot of cardamom to taste. If you want that dose, the cheapest and most potent route is a jar of whole pods and a mortar.

Who Should Take Cardamom

People with elevated HbA1c or triglycerides who want a low-risk dietary addition. The HbA1c signal (WMD -0.48) and the triglyceride signal (-14.09 mg/dL) are the two most consistent findings across meta-analyses. Neither replaces metformin, a statin or weight loss.

People with metabolic-associated fatty liver disease. The Daneshi-Maskooni trials are the only human work showing improvement in ultrasound fatty liver grade and ALT with cardamom, in 87 patients over 3 months.

Women with PCOS. Cheshmeh and colleagues (2022, Eating and Weight Disorders) randomized 194 obese women to 3 g daily green cardamom plus a low-calorie diet or the diet alone for 4 months, and found TNF-alpha, IL-6 and CRP reduced (P < 0.001), with luteinizing hormone, androstenedione and DHEA down and FSH up. Both arms lost weight, so the diet is doing part of the work.

People with functional dyspepsia and gas. Cardamom’s oldest and most defensible use, at Commission E’s 1.5 g daily.

People undergoing procedures with a high nausea risk. Inhaled cardamom oil has a small positive randomized dataset in postoperative nausea.

Anyone who cooks. Cardamom makes food taste good at six calories per teaspoon and carries a modest metabolic upside for free.

Who Should AVOID or Use Caution

Contraindications

• Known allergy to cardamom or to other Zingiberaceae including ginger, turmeric or galangal. Cross-reactivity within the family appears in contact dermatitis reports.
• Medicinal doses in pregnancy. Reference databases flag a theoretical miscarriage concern above culinary amounts. Food-level cardamom is not the issue; 3 g daily capsules are unstudied in pregnancy, and none of the six Iranian RCTs enrolled pregnant women.

Use Caution

• Active gallstone disease. Cardamom is a traditional cholagogue and stimulates bile flow, the mechanism by which a bile-stimulating herb can provoke biliary colic in someone with stones. No controlled human data exists either way, so this is a mechanistic caution, not a documented harm.
• Type 2 diabetes on glucose-lowering therapy. Aghasi 2019 saw HbA1c fall 0.4 percent and HOMA-IR fall 1.7 in 41 patients on gliclazide.
• Breastfeeding at medicinal doses. No data.
• Children. No pediatric dosing trial exists at any dose.
• Undiagnosed abdominal pain. Do not treat it with a carminative spice.

Critical Safety Point

The safety record here is a culinary safety record. 21 CFR 182.10 lists cardamom as generally recognized as safe as a spice, and the longest controlled human exposure on record is 4 months at 3 g daily in 99 women. Nothing establishes the safety of concentrated cardamom essential oil taken by mouth, and the gap between eating the spice and swallowing its distilled oil is large enough to matter.

Recommended Dosages

Whole pods, culinary. 2 to 6 pods per serving, crushed immediately before use. Eight to nine pods yield about 1 teaspoon of ground seed, roughly 2 g.

Ground cardamom, digestive use. 1.5 g per day, the Commission E average daily dose for dyspeptic complaints, divided across meals. Roughly three quarters of a teaspoon.

Ground cardamom, metabolic use. 3 g per day, the dose used in every published RCT: Kazemi 2017 (n = 80, 8 weeks), Fatemeh 2017 (n = 80, 2 months), Aghasi 2019 (n = 83, 10 weeks), Daneshi-Maskooni 2018 and 2019 (n = 87, 3 months) and Cheshmeh 2022 (n = 194, 4 months).

Tincture. 1 to 2 g of drug equivalent daily per the Commission E monograph. Uncommon outside compounded digestive bitters.

Essential oil, inhaled. The Khatiban trial used gauze pads moistened with cardamom essential oil in a plastic bag, inhaled at the first episode of nausea. No standardized drop count has been validated.

Essential oil, oral. No established dose. Do not extrapolate from the 1,8-cineole trials, which used the isolated compound at 200 mg three times daily, not cardamom oil.

Duration

Trial durations run 8 weeks to 4 months, and twelve weeks is a fair trial for metabolic endpoints. Nothing longer than 4 months has been studied, so open-ended daily supplementation at 3 g is beyond the evidence. Culinary use has no time limit.

Timing & Administration

With food. Daneshi-Maskooni dosed 500 mg capsules three times daily with meals, the schedule with the most supporting data. Cardamom’s volatile oil is lipophilic, so a meal containing fat is the sensible vehicle.

Divided rather than single. Verma’s 2009 trial gave 3 g in two divided doses across 12 weeks, and every metabolic trial divided the dose. No trial has tested 3 g as a single bolus.

Crush at the point of use. The instruction that matters most, and no label carries it. Ambient grinding costs 55 percent of the volatile oil immediately and warm storage costs half the remainder over 90 days.

Storage. Whole pods in an airtight container away from light and heat. If you must keep ground cardamom, refrigerate it. In the 90-day study, refrigeration at 4 degrees held volatile oil at 4.4 percent versus 2.9 percent at ambient.

Timeline of Effects

Immediate, within minutes. Aroma and carminative effect. Chewing a pod produces a cooling sensation traceable to 1,8-cineole acting as a TRPM8 agonist. Inhaled cardamom oil reduced nausea severity within the same operative episode in the Khatiban trial.

Two to four weeks. Nothing consistently measurable in blood. No trial reported an interim metabolic endpoint earlier than 8 weeks.

Eight weeks. The shortest positive metabolic trial. Kazemi 2017 found hs-CRP (P = 0.02), the hs-CRP to IL-6 ratio (P = 0.008) and malondialdehyde (P = 0.009) all reduced in 80 pre-diabetic women.

Ten to twelve weeks. Aghasi 2019 saw HbA1c down 0.4 percent, insulin down 2.8 microIU/dL, HOMA-IR down 1.7 and triglycerides down 39.9 mg/dL at 10 weeks. Verma 2009 recorded a 90 percent rise in total antioxidant status at 12 weeks.

Three to four months. Daneshi-Maskooni’s fatty liver grade improvement came at 3 months, Cheshmeh’s gene expression changes at 4 months.

What counts as a fair trial. Twelve weeks at 3 g daily of cardamom you ground yourself, with a before-and-after lipid panel and HbA1c. If triglycerides and HbA1c have not moved by then, they are not going to.

Benefits of Taking Cardamom

Triglyceride reduction is the most replicated finding. Asbaghi and colleagues (2020, Clinical Nutrition ESPEN) pooled 7 trials and found triglycerides significantly reduced. Aghasi’s single trial recorded -39.9 mg/dL in type 2 diabetics at 10 weeks, roughly triple the pooled figure.

Gene expression changes, not only serum proteins. Cheshmeh’s PCOS trial measured TNF-alpha and CRP transcripts by RT-PCR in 99 women and found both reduced (P < 0.001), which is stronger evidence than a protein assay alone.

Serum sirtuin-1 rises. Both Aghasi 2019 (+2.3 ng/mL) and Daneshi-Maskooni 2018 reported increased SIRT1, the proposed mechanistic link to the glucose and lipid findings.

Antioxidant status improves unevenly. Verma 2009 reported total antioxidant status up 90 percent at 3 months and Kazemi 2017 found malondialdehyde reduced (P = 0.009), but Zhang’s pooled analysis found no effect on several other oxidative stress indices.

Rescue antiemetic use drops. 37.1 percent versus 65.7 percent (P = 0.009) in the inhalation trial.

Oral antibacterial activity in vitro. Cardamom essential oil inhibited Streptococcus mutans at a minimum inhibitory concentration of 2.5 percent v/v and a bactericidal concentration of 5.0 percent v/v. Chewing a pod after a meal is a breath practice, not a caries treatment.

Potential Negatives & Side Effects

Reported adverse events in trials are close to nil. Verma’s 20 subjects reported no side effects across 12 weeks, and none of the Iranian RCTs reported a significant adverse event profile at 3 g daily for up to 4 months.

Gastrointestinal upset. Any concentrated aromatic spice in gram quantities can produce heartburn, belching or loose stools in sensitive people, through the same lower esophageal sphincter relaxation that makes cardamom a carminative.

Contact and oral mucosal reactions. Sensitization is uncommon but documented, presenting as cheilitis or perioral dermatitis with heavy occupational exposure.

Weight. Asbaghi’s 2020 meta-analysis found a significant BMI increase across 3 small studies, while Nameni’s 2022 analysis of 6 trials found no effect on BMI, weight or waist circumference. Neither is large. Treat cardamom as weight neutral.

Cost. At 3,064 rupees per kilogram wholesale, a 3 g daily habit costs roughly 9 rupees a day and far more at Western retail. Paying a third-most-expensive-spice premium for a powder that has lost three quarters of its marker compound is the real downside.

Deficiency Symptoms

No deficiency state exists, because cardamom is a seasoning rather than a required nutrient. There is no recommended intake, no deficiency syndrome, no blood test and no population with a documented cardamom shortfall. Nothing in human physiology requires Elettaria cardamomum.

What cardamom addresses

• Functional dyspepsia, gas and postprandial bloating, the Commission E indication
• Elevated triglycerides and HbA1c at the margins, on a pooled effect that is real and small
• Chronic low-grade inflammation as measured by hs-CRP, IL-6 and TNF-alpha
• Elevated ALT and ultrasound fatty liver grade in overweight NAFLD patients
• Procedural nausea, by inhalation
• Manganese intake, incidentally, at 0.56 mg per teaspoon

Bottom line

Nothing on that list is a deficiency being corrected. Each is a condition modestly influenced by a food-grade aromatic. If someone frames cardamom as replenishing something your body lacks, they have confused a spice with a nutrient.

Toxicity Symptoms

At high intake

No human toxic dose for cardamom powder has been established, and no case report of poisoning from culinary or supplemental cardamom appears in the indexed literature. The highest documented sustained exposure is 3 g daily for 4 months in 99 women. For the essential oil, the EFSA FEEDAP panel concluded in 2019 that cardamom seed oil is safe in animal feed at 5 mg per kg of feed and 5 mg per liter of drinking water, a feed-additive ceiling that says nothing about human oral dosing. Concentrated essential oils of any Zingiberaceae species can cause mucosal irritation, nausea and central nervous system depression if swallowed in quantity, and 1,8-cineole has documented toxicity in children who ingested eucalyptus-type oils.

Signs to reduce or stop

• Persistent heartburn, epigastric burning or nausea after starting a 3 g daily regimen
• Right upper quadrant pain, which in someone with known gallstones warrants stopping and a clinical evaluation
• Skin rash, mouth or lip swelling, or itching, pointing to Zingiberaceae sensitization
• Hypoglycemic symptoms in someone on sulfonylureas or insulin who added cardamom without adjusting monitoring

General note

The realistic risk with cardamom is not overdose. It is swallowing a concentrated essential oil formulated as a flavoring under 21 CFR 182.20 and treating it as an oral supplement, or letting a modest HbA1c effect substitute for treatment that works.

How Cardamom Works

1,8-cineole and the inflammatory pathway. Greiner and colleagues (2013) showed that 1,8-cineole reduces nuclear translocation of NF-kappaB p65 and NF-kappaB-dependent transcription in human U373 and HeLa cells stimulated with lipopolysaccharide. That is the most direct published mechanism for the hs-CRP, IL-6 and TNF-alpha reductions in the cardamom trials.

The cold receptor. Takaishi and colleagues (2012, Molecular Pain) identified 1,8-cineole as an agonist of human TRPM8 that does not activate TRPA1 and antagonizes it dose-dependently against allyl isothiocyanate, menthol, flufenamic acid and octanol. Cooling without irritation explains the sensory profile of a crushed pod and gives a plausible route for the antinausea observations.

Sirtuin-1. Both Aghasi 2019 and Daneshi-Maskooni 2018 measured serum SIRT1 and found it elevated in the cardamom arm, +2.3 ng/mL in the diabetic trial. SIRT1 is a NAD-dependent deacetylase that suppresses NF-kappaB signaling and promotes hepatic fatty acid oxidation, tying the inflammatory and lipid findings to one node. Causal direction has not been demonstrated in humans.

Carminative action. Cardamom’s terpenes relax gastrointestinal smooth muscle and reduce the surface tension of gas bubbles trapped in chyme.

Cholinesterase inhibition. Sharma and colleagues (2024) reported cardamom extracts inhibiting acetylcholinesterase at an IC50 of 130 to 150 micrograms per mL and isolated alpha-terpinyl acetate at 61.87, against 374.2 for anethole. An enzyme assay, not a cognitive claim.

Why form determines mechanism. Every mechanism above runs through the volatile fraction. Remove it, as grinding and storage demonstrably do, and there is no mechanism left. A powder retaining 26 percent of its 1,8-cineole retains 26 percent of its NF-kappaB pathway.

Synergistic Supplements

Other Zingiberaceae in the diet. Azimi and colleagues (2014 and 2016) tested cinnamon, cardamom and ginger at 3 g daily and saffron at 1 g daily in type 2 diabetics and found small, spice-dependent effects on glycemic and endothelial markers. Combining them is culinary common sense, not a documented synergy.

Black pepper. Paired with cardamom in chai and in supplement stacks on the argument that piperine improves bioavailability. That data is for curcumin, not cineole or terpinyl acetate, and no cardamom-specific piperine study exists. The pairing is a flavor decision.

Dietary energy restriction. Cheshmeh’s PCOS trial gave a low-calorie diet to both arms and still saw a cardamom effect on inflammatory markers, the strongest evidence that cardamom adds something on top of a diet intervention.

What does not stack. No published combination trial of cardamom with a statin, metformin, berberine or omega-3s exists. Anything claiming a validated cardamom stack is describing a formulation choice, not a finding.

Interactions & What NOT to Take

Documented human drug interactions: none. No clinically documented cardamom drug interaction appears in the major reference databases, and the Commission E monograph records none. That also reflects that almost nobody has looked.

Glucose-lowering drugs, mechanistic caution. Aghasi’s 41 cardamom-arm patients were on gliclazide, and HbA1c fell 0.4 percent and HOMA-IR 1.7 relative to control. Adding 3 g daily to gliclazide, glipizide, glimepiride or insulin is an additive glucose-lowering decision, small but real.

Antihypertensives, mechanistic caution. Verma’s 3 g daily lowered systolic, diastolic and mean blood pressure at P < 0.001 in 20 stage 1 hypertensives, though the pooled effect across 8 studies was only 0.54 mmHg systolic. The pooled number says the risk is minimal.

Anticoagulants and antiplatelets, mechanistic caution. Verma reported a significant increase in fibrinolytic activity (P < 0.05) with fibrinogen unchanged. One 20-person study, no bleeding signal anywhere in the literature, but the only hemostatic finding on record, so people on warfarin, apixaban or clopidogrel should mention gram-dose cardamom to whoever manages their anticoagulation.

Do not swallow the essential oil. FEMA 2241, CAS 8000-66-6, a flavoring material with no oral trial to draw on.

Do not substitute for prescribed therapy. A pooled HbA1c reduction of 0.48 is roughly a third of what metformin delivers. An addition, not a replacement.

Quality, Testing & Adulteration

Species substitution is the first problem. Three unrelated plants are sold as cardamom. Elettaria cardamomum (L.) Maton is green or true cardamom. Amomum subulatum Roxb. is black or large cardamom, from the eastern Himalayas, Sikkim and eastern Nepal, flue-cured over fire, which gives it a smoky profile no green cardamom has. Aframomum corrorima (Braun) P.C.M. Jansen is Ethiopian korarima. Noumi and colleagues (2018, Molecules) profiled all three by GC-MS: E. cardamomum ran 71.4 percent oxygenated monoterpenes with 1,8-cineole at 55.4 percent and alpha-terpinyl acetate at 28.6 percent; A. corrorima 63.0 percent with cineole at 51.8 percent; A. subulatum 51.0 percent with cineole at 41.7 percent and geraniol at 12.5 percent. Different plants, different chemistry, and black cardamom is routinely cheaper. In ground form the substitution is invisible.

Geographic origin changes the chemistry inside the same species. Zacharia and Gopalam (1987) measured the two markers by gas chromatography across origins: Guatemalan cardamom at 23.4 percent 1,8-cineole and 50.7 percent alpha-terpinyl acetate, Mysore at 49.5 and 30.6, Alleppey at 34.2 and 37.7, Papua New Guinea at 63.0 and 29.0. Guatemala supplies the majority of European imports, with India, Honduras and Tanzania accounting for much smaller shares. If a claim rests on 1,8-cineole, Guatemalan material carries roughly a third of what Papua New Guinean material does, and no label states origin.

Bulking and coloring of powder. Ground cardamom is adulterated with spent husk, exhausted seed left from oil distillation, starch and cheaper ginger-family powders. Husk is fiber, so bulking with it barely moves the ash or fiber assay while it dilutes the volatile oil. Green dyes are documented in ground spice generally, which is why color is not a purity signal.

Regulatory and contaminant record. Sixteen RASFF notifications for cardamom have been issued since 2021, including 13 pesticide residue cases between July 2021 and August 2024, mostly on Indian material. EU limits are 5 micrograms per kg for aflatoxin B1 and 10 for total aflatoxins, with Salmonella required absent.

What third-party testing exists. There is no USP or NSF monograph for cardamom as a dietary supplement ingredient, and ConsumerLab has not published a cardamom category test. The available public standards are food standards: ISO 882-1 and 882-2, the European Spice Association minima, and 21 CFR 182.10 and 182.20.

What a buyer can actually verify. Very little on a supplement label, and quite a lot on a jar of whole pods. A pod you can see is a pod you can assess: intact, unsplit, deep green rather than bleached, plump rather than shriveled, aromatic the moment you crush one. ISO 882-1 caps empty and malformed capsules at 5 percent by count and immature or shriveled ones at 7 percent, and you can count those from a handful. No bottle of powder permits any of that. The verifiable form and the potent form are the same form, which is not a coincidence.

Special Considerations

Pregnancy and lactation. Culinary cardamom is eaten daily through pregnancy across South Asia and the Middle East. Medicinal doses are a separate question with no data. The Khatiban inhalation trial enrolled women at cesarean delivery and reported no adverse effects, which covers acute aromatic exposure only.

Type 2 diabetes. The population with the best cardamom data, and the population where treating a 0.4 point HbA1c change as meaningful therapy is most dangerous.

Cost sensitivity. Whole pods cost more per gram than powder and less per unit of active compound. A 100 g jar is roughly 33 to 50 teaspoons of freshly ground seed at full volatile strength.

Climate and supply. National figures for Indian small cardamom in recent seasons have run well below the 41,000 tonne figure for India in the 2022 global series, reflecting year-to-year variation and differing accounting. Cardamom is a shade crop with a narrow altitude and rainfall window, and prices swing hard on monsoon outcomes. A sudden discount on cardamom powder is worth a second look.

Research Status & Evidence Quality

Strong Evidence For

• Nothing at the level of large multicenter trials with hard clinical endpoints. Cardamom has no mortality, morbidity or event-rate data of any kind.
• The volatile oil chemistry itself is settled: 24 constituents at 98.1 to 100 percent of the oil across 22 accessions, two markers dominating, and reproducible GC-MS profiles across four decades.

Moderate Evidence For

• Triglyceride reduction. Two independent meta-analyses agree, pooling 7 and 12 trials.
• hs-CRP and IL-6 reduction. Three meta-analyses agree across 8 to 12 trials and 989 participants.
• HbA1c reduction of roughly 0.4 to 0.5 units, pooled across 6 RCTs and 410 participants.
• ALT and ultrasound fatty liver grade in overweight NAFLD patients, from one 87-patient trial with a registered protocol.
• Antinausea effect by inhalation, from one 70-patient randomized trial.
• Volatile loss on grinding and storage, from one detailed measurement series with a coherent mechanism and a 1962 qualitative precedent.

Emerging / Preliminary Evidence For

• Sirtuin-1 elevation as the mediating mechanism. Two trials measured it. Neither demonstrated causation.
• Inflammatory gene expression changes, from a single 194-patient PCOS trial using RT-PCR.
• Blood pressure reduction. Verma’s 20-person trial found a large effect at P < 0.001 while the 8-study pooled effect is 0.54 mmHg systolic. Trust the pooled figure.
• Antimicrobial and cholinesterase-inhibiting activity, in vitro only.

Research Limitations

• Geographic concentration. Effectively the entire clinical literature comes from a small number of Iranian research groups with overlapping personnel, between 2016 and 2022. Sotoudeh is a coauthor on Kazemi 2017, Fatemeh 2017, Aghasi 2019 and Daneshi-Maskooni 2018 and 2019, with Koohdani, Siassi and Qorbani each appearing on several of them. Independent replication outside Iran does not exist.
• Single dose tested. Every trial used 3 g daily. No dose-response curve, no minimum effective dose, no test of whether 1.5 g or 6 g behaves differently.
• No trial characterized its own material. Not one of the six RCTs reports the volatile oil content, 1,8-cineole percentage or geographic origin of the cardamom it encapsulated. Given ranges of 4.5 to 9.5 percent oil and 15.2 to 49.4 percent cineole across accessions, the active dose is unknown to within a factor of three.
• Placebo choice. Several trials used rusk or toast powder, contributing starch and calories, not aroma-matched, so blinding of a strongly scented spice is questionable.
• Negative results matter. Fatemeh 2017 concluded that cardamom improved some parameters but that its effects were not different from placebo. Fasting blood sugar, insulin, QUICKI, weight, BMI and waist circumference were all null in Nameni’s pooled analysis, HDL-C and LDL-C null in Zhang’s.
• Direction conflicts. Asbaghi 2020 found BMI significantly increased; Nameni 2022 found no BMI effect.
• The form question is untested clinically. No trial has compared fresh-ground cardamom against aged powder at the same weight, the one comparison that would settle whether the null results reflect a weak spice or a degraded one.

Summary & Key Takeaways

Cardamom is a real pharmacological agent with a small replicated effect on triglycerides, HbA1c and inflammatory markers, and a well-documented vulnerability: the active fraction evaporates. Six randomized trials at 3 g daily, covering 410 participants in the pooled glycemic analysis and 989 across the lipid and inflammation pools, produce modest consistent findings. None measured the volatile oil content of the powder used, and the grinding data says that content could plausibly have varied threefold between studies. That is the central unresolved problem in cardamom research, and the same problem facing anyone in a store deciding what to buy.

Bottom Line

Buy whole green pods and crush them when you use them. Conventional grinding costs 55 percent of the volatile oil and 74 percent of the 1,8-cineole on the spot, and ninety days at room temperature takes half of what is left. A capsule of pre-ground cardamom is the most expensive way to buy the least active version of a spice that ranks third in the world by price. Use 1.5 g daily for digestion, 3 g daily for twelve weeks to test the metabolic effect, and judge it on a lipid panel rather than on how you feel.

Key Safety Points

• Culinary amounts are GRAS under 21 CFR 182.10 and carry no meaningful risk
• 3 g daily has been tested safely for up to 4 months in 99 women, with no adverse event signal in any trial
• Avoid medicinal doses in pregnancy and with active gallstones
• Monitor glucose if you take sulfonylureas or insulin
• Do not swallow cardamom essential oil; it is a flavoring material, not an oral supplement

Special Note

The pod is the most sophisticated piece of packaging in your kitchen, and it is free with the product. A cardamom capsule is a container someone charged you for, holding the contents of a container they threw away.